Advertisement

Acyl-Carbon Bond Cleaving Cytochrome P450 Enzymes: CYP17A1, CYP19A1 and CYP51A1

  • Muhammad AkhtarEmail author
  • J. Neville Wright
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 851)

Abstract

Cytochrome P450 (P450 or CYP) enzymes in their resting state contain the heme-iron in a high-spin FeIII state. Binding of a substrate to a P450 enzyme allows transfer of the first electron, producing a FeII species that reacts with oxygen to generate a low-spin iron superoxide intermediate (FeIII–O–O) ready to accept the second electron to produce an iron peroxy anion intermediate (a, FeIII–O–O). In classical monooxygenation reactions, the peroxy anion upon protonation fragments to form the reactive Compound I intermediate (Por•+FeIV=O), or its ferryl radical resonance form (FeIV–O). However, when the substrate projects a carbonyl functionality, of the type b, at the active site as is the case for reactions catalyzed by CYP17A1, CYP19A1 and CYP51A1, the peroxy anion (FeIII–O–O) is trapped, yielding a tetrahedral intermediate (c) that fragments to an acyl-carbon cleavage product (d plus an acid). Analogous acyl-carbon cleavage reactions are also catalyzed by certain hepatic P450s and CYP125A1 from Mycobacterium tuberculosis. A further improvisation on the theme is provided by aldehyde deformylases that convert long-chain aliphatic aldehydes to hydrocarbons. CYP17A1 is involved in the biosynthesis of corticoids as well as androgens. The flux toward these two classes of hormones seems to be regulated by cytochrome b 5, at the level of the acyl-carbon cleavage reaction. It is this regulation of CYP17A1 that provides a safety mechanism, ensuring that during corticoid biosynthesis, which requires 17α-hydroxylation by CYP17A1, androgen formation is avoided (Fig. 4.1).

Keywords

Aromatase Sterol 14α-demethylase 17α-hydroxylase-17,20-lyase P450 2B4 CYP125A1 Aldehyde deformylase Cytochrome b5 in CYP17A1 catalysis 

Notes

Reviews

Apart from citations in the text [2, 5, 6, 7, 8, 75], useful reviews dealing with specific aspects of the subject are available [80, 81].

Note added in proof

Recently another alternative to the mechanism of Scheme 4.11 has been suggested (Yoshimoto FK, Guengerich FP, J Am Chem Soc 136: 15016–25).

Acknowledgments

We acknowledge with pleasure the help of Dr. Peter Lee-Robichaud in writing the section on the interaction of CYP17A1 with cytochrome b 5, an area in which he has made seminal contributions.

References

  1. 1.
    Omura T, Sato RA (1962) New cytochrome in liver microsomes. J Biol Chem 237:1375–1376PubMedGoogle Scholar
  2. 2.
    Ortiz de Montellano PR (2005) Cytochrome P-450: structure, mechanism, and biochemistry, 3rd edn. Kluwer Academic/Plenum Press, New YorkCrossRefGoogle Scholar
  3. 3.
    Akhtar M, Calder MR, Corina DL, Wright JN (1981) The status of oxygen atoms in the removal of C-19 in oestrogen biosynthesis. J Chem Soc Chem Commun:129−131Google Scholar
  4. 4.
    Akhtar M, Calder MR, Corina DL, Wright JN (1982) Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. Biochem J 201:569–580PubMedCentralPubMedGoogle Scholar
  5. 5.
    Stevenson DE, Wright JN, Akhtar M (1988) Mechanistic consideration of P-450 dependent enzymic reactions: studies on oestriol biosynthesis. J Chem Soc Perkin Trans 1:2043–2052CrossRefGoogle Scholar
  6. 6.
    Akhtar M, Wright JN (1991) A unified mechanistic view of oxidative reactions catalysed by P-450 and related Fe-containing enzymes. Nat Prod Rep 8:527–551CrossRefPubMedGoogle Scholar
  7. 7.
    Groves JT (2005) Models and mechanisms of cytochrome P450 action. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 3rd edn. Kluwer Academic/Plenum Publishers, New York, pp 1–43CrossRefGoogle Scholar
  8. 8.
    Makris TM, Denisov I, Schlichting I, Sligar SG (2005) Activation of molecular oxygen by cytochrome P450. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 3rd edn. Kluwer Academic/Plenum Publishers, New York, pp 149–182CrossRefGoogle Scholar
  9. 9.
    Sharrock M, Debrunner PG, Shultz C, Lipscomb JD, Marshall VP, Gunsalus IC (1976) Cytochrome P-450cam and its complexes: mossbauer parameter of the haem-iron. Biochim Biophys Acta 420:8–26CrossRefPubMedGoogle Scholar
  10. 10.
    Weiss JJ (1964) Nature of the iron-oxygen bond in oxyhaemoglobin. Nature 202:83–84CrossRefPubMedGoogle Scholar
  11. 11.
    Pauling L (1964) Nature of the iron–oxygen bond in oxyhæmoglobin. Nature 203:182–183CrossRefGoogle Scholar
  12. 12.
    Morato T, Hyano M, Dorfman RI, Axelrod LR (1961) The intermediate steps in the biosynthesis of estrogens from androgens. Biochem Biophys Res Commun 20:334–338CrossRefGoogle Scholar
  13. 13.
    Ryan KJ (1959) Biological aromatisation of steroids. J Biol Chem 234:268–272PubMedGoogle Scholar
  14. 14.
    Akhtar M, Skinner SJM (1968) The intermediary role of a 19-oxoandrogen in the biosynthesis of oestrogen. Biochem J 109:318–321PubMedCentralPubMedGoogle Scholar
  15. 15.
    Skinner SJM, Akhtar M (1969) The stereospecific removal of a C-19 hydrogen atom in oestrogen biosynthesis. Biochem J 114:75–81PubMedCentralPubMedGoogle Scholar
  16. 16.
    Arigoni D, Battaglia R, Akhtar M, Smith T (1975) Stereospecificity of oxidation at C-19 in oestrogen biosynthesis. J Chem Soc Chem Commun 185–186Google Scholar
  17. 17.
    Osawa Y, Shibata K, Rohrer D, Week C, Duax WL (1975) Reassignment of the absolute configuration of 19-substituted 19-hydroxysteroids and stereomechanism of estrogen biosynthesis. J Am Chem Soc 97:4400–4402CrossRefPubMedGoogle Scholar
  18. 18.
    Thompson EA, Siiteri PK (1974) Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 249:5364–5374PubMedGoogle Scholar
  19. 19.
    Bloch K (1965) The biological synthesis of cholesterol. Science 150:19–28CrossRefPubMedGoogle Scholar
  20. 20.
    Miller WL, Brady DR, Gaylor JL (1971) Investigation of the component reactions of oxidative demethylation of sterols: metabolism of 4α-hydroxymethyl steroids. J Biol Chem 246:5147–5153PubMedGoogle Scholar
  21. 21.
    Bloxham DP, Wilton DC, Akhtar M (1971) Studies on the mechanism and regulation of C-4 demethylation in cholesterol biosynthesis: the role of adenosine 3′,5′- cyclic monophosphate. Biochem J 125:625–634PubMedCentralPubMedGoogle Scholar
  22. 22.
    Rahier A (2011) Dissecting the sterol C-4 demethylation process in higher plants. From structures and genes to catalytic mechanism. Steroids 76:350–352CrossRefGoogle Scholar
  23. 23.
    Olson JA, Landberg M, Bloch K (1957) On the demethylation of lanosterol to cholesterol. J Biol Chem 228:941–956Google Scholar
  24. 24.
    Canonica L, Fiecchi A, Kienele MG, Scala A, Galli G, Paoletti EG, Paoletti RJ (1968) The fate of the 15-beta hydrogen of lanosterol in cholesterol biosynthesis. J Am Chem Soc 90:3597–3598CrossRefPubMedGoogle Scholar
  25. 25.
    Akhtar M, Rahimtula AD, Watkinson IA, Wilton DC, Munday KA (1969) The status of C-6, C-7, C-15 and C-16 hydrogen atoms in cholesterol biosynthesis. Eur J Biochem 9:107–111CrossRefPubMedGoogle Scholar
  26. 26.
    Gibson GF, Goad LJ, Goodwin TW (1968) J Chem Soc Chem Commun:1458−1460Google Scholar
  27. 27.
    Watkinson IA, Wilton DC, Munday KA, Akhtar M (1971) The formation and reduction of the 14,15-double bond in cholesterol biosynthesis. Biochem J 121:131–137PubMedCentralPubMedGoogle Scholar
  28. 28.
    Akhtar M, Freeman CW, Wilton DC, Boar RB, Copsey DB (1977) The pathway for the removal of the 14α-methyl group of lanosterol: the role of lanost-8-ene-3β,32-diol in cholesterol biosynthesis. Bioorg Chem 6:473–481CrossRefGoogle Scholar
  29. 29.
    Akhtar M, Alexander K, Boar RB, McGhie JF, Barton DHR (1978) Chemical and enzymic studies on the characterisation of intermediates during the removal of the 14α-methyl group in cholesterol biosynthesis. Biochem J 169:449–463PubMedCentralPubMedGoogle Scholar
  30. 30.
    Shyadehi AZ, Lamb DC, Kelly SL, Kelly DE, Schunck WH, Wright JN, Corina D, Akhtar M (1996) The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14α-demethylase of Candida albicans (other names are: lanosterol 14α-demethylase, P-45014DM and CYP51). J Biol Chem 271:12445–12450CrossRefPubMedGoogle Scholar
  31. 31.
    Nakajin S, Hall SPF, Onoda M (1981) Testicular microsomal cytochrome P-450 for C21 steroid side chain cleavage. Spectral and binding studies. J Biol Chem 256:6134–6139PubMedGoogle Scholar
  32. 32.
    Nakajin S, Takahashi M, Shinoda M, Hall SPF (1985) Cytochrome b5 promotes the synthesis of Δ16–C19 steroids by homogeneous cytochrome P-450 C21 side-chain cleavage from pig testes. Biochem Biophys Res Commun 132:708–713CrossRefPubMedGoogle Scholar
  33. 33.
    Lee-Robichaud P, Wright JN, Akhtar ME, Akhtar M (1995) Modulation of the activity of human 17α-hydroxylase-17,20-lyase (CYP17) by cytochrome b 5: endocrinological and mechanistic implications. Biochem J 308:901–908PubMedCentralPubMedGoogle Scholar
  34. 34.
    Gower BD, Holland KT, Mallet AI, Rennie PJ, Watkins WJ (1994) Comparison of 16-androstene steroid concentrations in sterile apocrine sweat and axillary secretions: interconversion of 16-androstenes by the axillary microflora–a mechanism for axillary odour production on man? J Steroid Biochem Mol Biol 48:409–418CrossRefPubMedGoogle Scholar
  35. 35.
    Miller SL, Wright JN, Corina DL, Akhtar M (1991) Mechanistic studies on pregnene side-chain cleavage enzyme (17α-hydroxylase-17,20-lyase) using 18O. J Chem Soc Chem Commun:157−159Google Scholar
  36. 36.
    Akhtar M, Corina DL, Miller SL, Shyadehi AZ, Wright JN (1994) Mechanism of the acyl-carbon cleavage and related reactions catalysed by multifunctional P-450s: studies on cytochrome P-45017α. Biochemistry 33:4410–4418CrossRefPubMedGoogle Scholar
  37. 37.
    Akhtar M, Corina DL, Miller SL, Shyadehi AZ, Wright JN (1994) Incorporation of label from 18O2 into acetate during side-chain cleavage catalysed by cytochrome P-45017α (17α-hyroxylase-17,20-lyase). J Chem Soc Perkin Trans 1:263–267CrossRefGoogle Scholar
  38. 38.
    Lee-Robichaud P, Shyadehi AZ, Wright JN, Akhtar ME, Akhtar M (1995) Mechanistic kinship between hydroxylation and desaturation reactions: acyl-carbon cleavage promoted by pig and human CYP17 (P-45017α; 17α-hydroxylase-17,20-lyase. Biochemistry 34:14104–14113CrossRefPubMedGoogle Scholar
  39. 39.
    Imai T, Globerman H, Gertner JM, Kagawa N, Waterman MR (1993) Expression and purification of functional human 17α-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17α-hydroxylase/17,20-lyase deficiency. J Biol Chem 268:19681–19689PubMedGoogle Scholar
  40. 40.
    Akhtar M, Corina DL, Pratt J, Smith T (1976) Studies on the removal of C-19 in oestrogen biosynthesis using 18O2. J Chem Soc Chem Commun:854−856Google Scholar
  41. 41.
    Gregory M, Mak PJ, Sligar SG, Kinkaid JR (2013) Differential hydrogen bonding in human CYP17 dictates hydroxylation versus lyase chemistry. Angew Chem Int Ed 52:5342–5345CrossRefGoogle Scholar
  42. 42.
    Sen K, Hackett JC (2012) Coupled electron transfer and proton hopping in the final step of CYP19-catalyzed androgen aromatization. Biochemistry 51:3039–3049CrossRefPubMedCentralPubMedGoogle Scholar
  43. 43.
    Cheng Q, Sohl CD, Yoshimoto FK, Guengerich FP (2012) Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4. J Biol Chem 287:29554–29567CrossRefPubMedCentralPubMedGoogle Scholar
  44. 44.
    Goto J, Fishman J (1977) Participation of a non-enzymic transformation in the biosynthesis of estrogens from androgens. Science 195:80–81CrossRefPubMedGoogle Scholar
  45. 45.
    Caspi E, Wicha J, Arunachalam T, Nelson P, Spiteller G (1984) Estrogen biosynthesis. Concerning the obligatory intermediary of 2β-hydroxy-10β-formylandrost-4-ene-3,17-dione. J Am Chem Soc 106:7282–7283CrossRefGoogle Scholar
  46. 46.
    Cole PA, Bean JM, Robinson CH (1990) Conversion of a 3-deoxysteroid to 3-deoxyestrogen by human placental aromatase. Proc Natl Acad Sci U S A 87:2999–3003CrossRefPubMedCentralPubMedGoogle Scholar
  47. 47.
    Numazawa M, Nagoaka M, Sohtome N (2005) Aromatase reaction of 3-deoxyandrogens: steric mode of the C-19 oxygenation and cleavage of the C10-C19 bond by human placental aromatase. Biochemistry 44:10839–10485CrossRefPubMedGoogle Scholar
  48. 48.
    Hackett JC, Brueggermeier RB, Hadad CM (2005) The final step of cytochrome P450 aromatase: a density functional theory study. J Am Chem Soc 127:5224–5287CrossRefPubMedGoogle Scholar
  49. 49.
    Gosh D, Griswold J, Erman M, Pangborn W (2009) Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 457:219–223CrossRefGoogle Scholar
  50. 50.
    Kadoharma N, Yarborough C, Zhou D, Chen S, Osawa Y (1992) Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn and Asp309Ala and their interactions with aromatase inhibitors. J Steroid Biochem Mol Biol 43:693–701CrossRefGoogle Scholar
  51. 51.
    Nagano S, Poulos TL (2005) Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism. J Biol Chem 280:31659–31663CrossRefPubMedGoogle Scholar
  52. 52.
    Nagano S, Cupp-Vickery JR, Poulos TL (2005) Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF. J Biol Chem 280:22102–22107CrossRefPubMedGoogle Scholar
  53. 53.
    Sen K, Hackett JC (2010) Peroxy-iron mediated deformylation in sterol 14α-demethylase catalysis. J Am Chem Soc 132:10293–10305CrossRefPubMedGoogle Scholar
  54. 54.
    Robichaud P, Wright JN, Akhtar M (1994) Involvement of an O2-derived nucleophilic species in acyl-carbon cleavage, catalysed by cytochrome P-45017α: implications for related P-450 catalysed fragmentation reactions. J Chem Soc Chem Commun:1501−1503Google Scholar
  55. 55.
    Roberts ES, Vaz ADN, Coon MJ (1991) Catalysis by cytochrome P-450 of an oxidative reaction in xenobiotic aldehyde metabolism: deformylation with olefin formation. Proc Natl Acad Sci U S A 88:8963–8966CrossRefPubMedCentralPubMedGoogle Scholar
  56. 56.
    Sivaramakrishnan S, Ouellet H, Matsumura H, Guan S, Moënne-Loccoz P, Burlingame AL, Ortiz de Montellano PR (2012) Proximal ligand electron donation and reactivity of the cytochrome P450 ferric–peroxo anion. J Am Chem Soc 134:6673–6684CrossRefPubMedCentralPubMedGoogle Scholar
  57. 57.
    Schirmer A, Rude MA, Li XZ, Popova E, del Cardayre SB (2010) Microbial biosynthesis of alkanes. Science 329:559–562CrossRefPubMedGoogle Scholar
  58. 58.
    Pandelia ME, Li N, Nørgaard H, Warui DM, Rajakovich LJ, Chang W, Booker SJ, Krebs C, Bollinger JM Jr (2013) Substrate-triggered addition of dioxygen to the diferrous cofactor of aldehyde-deformylating oxygenase to form a diferric-peroxide intermediate. J Am Chem Soc 135:15801–15812CrossRefPubMedGoogle Scholar
  59. 59.
    Katagiri M, Kagawa N, Waterman MR (1995) The role of cytochrome b5 in the biosynthesis of androgens by human P-450c17. Arch Biochem Biophys 317:343–347CrossRefPubMedGoogle Scholar
  60. 60.
    Lee-Robichaud P, Kaderbhai MA, Kaderbhai N, Wright JN, Akhtar M (1997) Interaction of human CYP17 (P-45017α, 17α-hydroxylase-17,20-lyase) with cytochrome b 5: importance of the orientation of the hydrophobic domain of cytochrome b 5. Biochem J 321:857–863PubMedCentralPubMedGoogle Scholar
  61. 61.
    Suzuki T, Sasano H, Sawai T, Mason JI, Nagura H (1992) Immunohistochemistry and in situ hybridization of P-45017α (17α-hydroxylase/17,20-lyase). J Histochem Cytochem 40:903–908CrossRefPubMedGoogle Scholar
  62. 62.
    Dharia S, Slane A, Jian M, Connor M, Conley A, Parker CR Jr (2004) Colocalization of P450c17 and cytochrome b5 in androgen-synthesizing tissues of the human. Biol Reprod 71:83–88CrossRefPubMedGoogle Scholar
  63. 63.
    Mapes S, Tarantal A, Parker CR Jr, Moran FM, Bahr JM, Pyter L, Conley A (2002) Adrenocortical cytochrome b5 expression during fetal development of the rhesus macaque. Endocrinology 143:1451–1458CrossRefPubMedGoogle Scholar
  64. 64.
    Kaneko TC, Freije WA, Carr BR, Rainey WE (2000) Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol 53:739–747CrossRefGoogle Scholar
  65. 65.
    Mason JI, Estabrook RW, Purvis JL (1973) Testicular cytochrome P-450 and iron-sulphur protein as related to steroid metabolism. Ann NY Acad Sci 212:406–419CrossRefPubMedGoogle Scholar
  66. 66.
    Sakai Y, Yanase T, Takayanagi R, Nakao R, Nishi Y, Haji M, Nawata H (1993) High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing’s syndrome associated with high secretion of adrenal androgens. J Clin Endocrinol Metab 76:1286–1290PubMedGoogle Scholar
  67. 67.
    Sakai Y, Yanase T, Hara T, Takayanagi R, Haji M, Nawata H (1994) In-vitro evidence for the regulation of 17,20-lyase activity by cytochrome b5 in adrenocortical adenomas from patients with Cushing’s syndrome. Clin Endocrinol Oxf 40:205–209CrossRefPubMedGoogle Scholar
  68. 68.
    Sakai Y, Yanase T, Hara T, Takayanagi R, Haji M, Nawata H (1994) Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab 78:36–40PubMedGoogle Scholar
  69. 69.
    Yanase T, Sasano H, Yubisui T, Sakai Y, Takayanagi R, Nawata H (1998) Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing’s syndrome. Endocr J 45:89–95CrossRefPubMedGoogle Scholar
  70. 70.
    Ravichandran KG, Boddupalli SS, Hasemann CA, Peterson JA, Deisenhofer J (1993) Crystal-structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science 261:731–736CrossRefPubMedGoogle Scholar
  71. 71.
    Geller DH, Auchus RJ, Mendonca BB, Miller WL (1997) The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 17:201–205CrossRefPubMedGoogle Scholar
  72. 72.
    Lee-Robichaud P, Akhtar ME, Akhtar M (1998) Control of androgen biosynthesis in the human through the interaction of Arg347 and Arg358 of CYP17 with cytochrome b 5. Biochem J 332:293–296PubMedCentralPubMedGoogle Scholar
  73. 73.
    Lee-Robichaud P, Akhtar ME, Akhtar M (1999) Lysine mutagenesis identifies cationic charges of human CYP17 that interact with cytochrome b 5 to promote male sex-hormone biosynthesis. Biochem J 342:309–312CrossRefPubMedCentralPubMedGoogle Scholar
  74. 74.
    Lee-Robichaud P, Akhtar ME, Wright JN, Sheikh QI, Akhtar M (2004) The cationic charges on Arg347, Arg358 and Arg449 of human cytochrome P450c17 (CYP17) are essential for the enzyme’s cytochrome b 5-dependent acyl-carbon cleavage activities. J Steroid Biochem Mol Biol 92:119–130CrossRefPubMedGoogle Scholar
  75. 75.
    Akhtar M, Wright JN, Lee-Robichaud P (2011) A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17). J Steroid Biochem Mol Biol 125:2–12CrossRefPubMedGoogle Scholar
  76. 76.
    Jacqueline L, Naffin-Olivos JL, Auchus RJ (2006) Human cytochrome b 5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17. Biochemistry 45:755–762CrossRefGoogle Scholar
  77. 77.
    Estrada DF, Laurence JE, Scott EE (2013) Substrate-modulated cytochrome P450 17A1 and cytochrome b 5 interactions revealed by NMR. J Biol Chem 288:17008–17018CrossRefPubMedCentralPubMedGoogle Scholar
  78. 78.
    Pompon D, Coon MJ (1984) On the mechanism of action of cytochrome P-450: oxidation and reduction of the ferrous dioxygen complex of liver microsomal cytochrome P-450 by cytochrome b 5. J Biol Chem 259:15377–15385PubMedGoogle Scholar
  79. 79.
    Mapes S, Corbin CJ, Tarantal A, Conley A (1999) The primate adrenal zona reticularis is defined by expression of cytochrome b5, 17α-hydroxylase/17,20-lyase cytochrome P450 (P450c17) and NADPH-cytochrome P450 reductase (reductase) but not 3β-hydroxysteroid dehydrogenase/Δ5-4-isomerase (3β-HSD). J Clin Endocrinol Metab 84:3382–3385PubMedGoogle Scholar
  80. 80.
    Hrycay EG, Bandiera SM (2012) The monooxygenase, peroxidase, and peroxygenase properties of cytochrome P450. Arch Biochem Biophys 522:71–89CrossRefPubMedGoogle Scholar
  81. 81.
    Wertz DL, Valentine JS (2000) Nucleophilicity of iron-peroxo porphyrin complexes. Struct Bonding 97:37–60Google Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.School of Biological SciencesUniversity of the PunjabLahorePakistan
  2. 2.Centre for Biological SciencesUniversity of SouthamptonSouthamptonUK

Personalised recommendations